Fiji Kava Limited (ASX:FIJ) has entered into a binding agreement to acquire Leilo Inc, in all stock acquisition and has completed a placement of $1.6m to sophisticated and institutional investors.
Fiji Kava Limited (ASX:FIJ) is a medicinal kava company based in Australia and the first foreign company with approval from the Fijian Government to operate in the kava industry.
Fiji Kava Limited (ASX:FIJ) an Australian-Fijian medicinal Kava company with operations across the USA, which produces nutraceutical and beverage products for the natural medicine market, is pleased to announce the appointment of James Dack as Non-Executive Director of the Company.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received ethics approval to proceed with a US pharmacokinetics and exercise clinical study.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has made significant progress in its Phase II clinical study in Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic SteatoHepatitis (NASH).
Fiji Kava Limited (ASX:FIJ) an Australian-Fijian medicinal Kava company which produces natural Noble Kava products for the natural medicine market, wishes to provide shareholders and investors with an overview of quarterly activities to accompany the Appendix 4C for the period ended 30 June 2022.
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 30 June 2022.
